News releases | Medicago

Medicago

Menu
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Behind the science
    • Our vaccine candidates
    • Our therapeutic antibody candidates
  • Our technologies
    Our technologies
    • Plant-based technology
    • Virus-like particles
  • Media
  • Behind the science
  • Careers
  • Culture
  • FAQ
  • Contact
  • fr
  • News releases

News releases

  • All
  • Antibodies 1
  • Corpo 7
  • Vaccine 18
  • Clinical trials 7
  • COVID-19 16
    • Antibodies
    October 29, 2015

    Medicago engaged by the Canadian government to develop Ebola monoclonal antibodies

    Press release Medicago 2015-2017
    Read more
Medicago
  • Media
  • Behind the science
  • Careers
  • Culture
  • FAQ
  • Contact
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Behind the science
    • Our vaccine candidates
    • Our therapeutic antibody candidates
  • Our technologies
    Our technologies
    • Plant-based technology
    • Virus-like particles
  • Legal
  • Privacy
  • Community guideline
  • Cookie policy
© Medicago Inc, 2021

This website uses cookies. Find out more

Medicago and GSK announce

COVID-19

Medicago submits Phase 3 data to Health Canada for its plant-based COVID-19 vaccine candidate.

Read more